Loading...
NPI 1346510476 · Tulsa, OK · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Tulsa Ambulatory Procedure Center LLC is a ambulatory surgical clinic/center provider located in Tulsa, Oklahoma. This profile covers 17 Medicare and 7 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Tulsa Ambulatory Procedure Center LLC |
| Address | 2811 E 15th St Ste 101 |
| City | Tulsa |
| State | OK |
| ZIP | 74104 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | January 5, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.8M |
| Medicaid | $199.4K |
TULSA AMBULATORY PROCEDURE CENTER LLC is registered as an Ambulatory Surgical Clinic/Center and its Medicare billing mix is concentrated in spine and neurostimulation procedures: 0627T, 63685, and 64590 are the top Medicare drivers and these three codes together account for 58.2% of the provider's total Medicare revenue. The individual Medicare revenues for those codes are $440.4K (0627T), $370K (63685), and $234.3K (64590), which aligns the site with advanced interventional spine care and implantable neurostimulator services.
Medicaid billing is heavily weighted toward fluoroscopically guided pain procedures and joint injections, with 64635 (radiofrequency/neurolytic lower back procedure), 64493 (lumbar/sacral facet injection), and 64483 (transforaminal epidural injection) comprising a very large share of activity. Those three Medicaid codes together account for 96.2% of this provider's total Medicaid revenue, and the listed Medicaid volumes include 466 claims/$100.2K for 64635 and 629 claims/$69.2K for 64493, indicating an injection-heavy Medicaid caseload.
The provider's overall payer-scale is Medicare-dominant: total Medicare revenue on file is $1.8M compared with total Medicaid revenue of $199.4K, so Medicare represents the primary revenue source for this practice. Given that imbalance, operational and contracting focus is likely to be driven by Medicare reimbursement dynamics rather than Medicaid.
Revenue concentration creates operational exposure: the precomputed top-3 shares show that 58.2% of Medicare revenue is concentrated in three codes and 96.2% of Medicaid revenue is concentrated in three codes, highlighting dependence on a narrow set of spine and pain interventions across both payers. That concentration suggests capacity, supply, and staffing requirements tailored to implanted neurostimulator cases and image-guided spine injections.
Competitive standing for key Medicare codes is mixed. 0627T ranks #8 of 68 nationally at the 88th percentile and is described as "typical, unremarkable volume," indicating this provider is relatively prominent among the modest national cohort billing that biologic disc injection code; by contrast 63685 (#422 of 1281, 64th percentile) and 64590 (#240 of 561, 52th percentile) are middle-tier placements nationally and are likewise characterized as "typical, unremarkable volume," supporting a view of a modest national footprint for implant procedures.
Within Oklahoma Medicaid comparisons the provider shows stronger in-state placement on core injection codes. 64635 ranks #4 of 13 (75th percentile), 64493 ranks #3 of 27 (92th percentile), and G0260 ranks #1 of 3 (100th percentile), with peer-comparison labels of "typical, unremarkable volume"; collectively this positions the center as a notable in‑state provider for facet and sacroiliac/similar image-guided injections.
Tenure and stability: the NPI was enumerated on 2012-01-05 (~14 years ago), indicating the entity has an established operating history as an ambulatory surgical site. That duration, combined with repeat billing in both Medicare and Medicaid across multiple years, suggests operational continuity in its specialty services.
Several spine and pain-related CPT/HCPCS codes appear at high percentile ranks even while peer comments label volumes as "typical, unremarkable volume," which merits attention when benchmarking utilization. Examples include Medicare placements such as 64635 at the 90th percentile (#596 of 5957), 64633 at the 92th percentile (#172 of 2262), and 64490 at the 93th percentile (#257 of 3759); these percentile positions indicate relatively elevated activity on neurolytic/facet-related services versus national peers and may warrant deeper peer-group analysis.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 0627T | The provider injects a cellular or tissue–based product under fluoroscopic guidance to treat a lumbar intervertebral disc. This code applies to the first level injected. The injection may occur on… | 70 | $6,480 | $440.4K |
| 63685 | The provider inserts or replaces a spinal neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that requires a connection… | 20 | $17,620 | $370K |
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 20 | $13,780 | $234.3K |
| 63650 | In this procedure, the provider places electrodes in the epidural space to relieve pain and reduce or eliminate spasms. | 60 | $3,500 | $210.1K |
| 64555 | A neurostimulator includes electrodes which are inserted under the skin and induced by a generator to stimulate the nerve tissue. Use of this stimulator involves implantation of electrodes around a… | 40 | $3,990 | $167.5K |
| 22869 | Through a minimally invasive approach, the provider inserts an interlaminar stabilization or interspinous distraction, or decompression, device (IPD) and attaches it to the bony projections (spinous… | 20 | $7,810 | $132.8K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 110 | $500 | $57.1K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 160 | $250 | $40.6K |
| 64633 | In this procedure, the provider destroys the facet joint nerve of a cervical or thoracic spinal segment using neurolytic agents like heat, electric current, or a chemical compound. He makes use of… | 60 | $520 | $32.4K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 120 | $250 | $30.6K |
Showing 1–10 of 17
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
17 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 63685 | 13 | 30 | 20 | $7,450 | $238.5K |
| 63650 | 14 | 30 | 70 | $1,510 | $158.8K |
| 0627T | 1 | 10 | 40 | $2,860 | $111.7K |
| 64590 | 11 | 30 | 20 | $4,440 | $88.8K |
| 64555 | 3 | 10 | 40 | $1,970 | $82.7K |
| 22869 | 6 | 10 | 20 | $1,940 | $40.8K |
| 64635 | 14 | 80 | 50 | $360 | $23.3K |
| 64483 | 19 | 100 | 80 | $160 | $18.4K |
| 62323 | 67 | 90 | 60 | $130 | $15K |
| 64633 | 6 | 40 | 30 | $350 | $12.7K |
Showing 1–10 of 17
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
7 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 470 | $220 | $100.2K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 630 | $110 | $69.2K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 200 | $110 | $22.5K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 70 | $80 | $5K |
| 64490 | The provider injects a diagnostic or therapeutic substance into a single cervical or thoracic paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging… | 30 | $90 | $2.5K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 10 | $1 | $50 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 20 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Oklahoma providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oklahoma median
7 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 4 | 10 | 320 | $320 | $137.9K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 9 | 20 | 140 | $170 | $113K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 3 | 30 | 110 | $170 | $36.5K |
| 64490 | The provider injects a diagnostic or therapeutic substance into a single cervical or thoracic paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging… | 3 | 10 | 40 | $180 | $10.6K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 38 | 40 | 60 | $30 | $9.4K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 1 | 10 | 10 | $130 | $3.8K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 1 | 10 | 20 | $0 | $0 |
Other providers in the same ZIP code as Tulsa Ambulatory Procedure Center LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.